GoldenGolden
Advanced Search
Mediphage Bioceuticals

Mediphage Bioceuticals

Mediphage Bioceuticals is a company developing cures to diseases founded by Roderick Slavcev.

Mediphage Bioceuticals is a non-viral gene therapy company focused on developing gene therapies for patients worldwide. The company's flagship technology, ministring DNA, is a form of non-viral transgene delivery.

Timeline

March 2019
Mediphage Bioceuticals raises a $3,500,000 convertible note from Family Office, Viking Global Investors and Wing Venture Capital.
March 1, 2018
Mediphage Bioceuticals raises a $646,000 seed round.

Funding rounds

People

Name
Role
LinkedIn

Lee Bowman

Employee

Roderick Slavcev

Founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.